Articles

• Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1Redefining DYT14 as DYT5

  C. Wider, S. Melquist, M. Hauf, A. Solida, S. A. Cobb, J. M. Kachergus, J. Gass, K. D. Coon, M. Baker, A. Cannon, D. A. Stephan, D. F. Schorderet, J. Ghika, P. R. Burkhard, G. Kapatos, M. Hutton, M. J. Farrer, Z. K. Wszolek, F.J.G. Vingerhoets

  • Abstract
  • Full Text
  • Full Text (PDF)
• SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia

  C. Paisan-Ruiz, O. Dogu, A. Yilmaz, H. Houlden, A. Singleton

  • Abstract
  • Full Text
  • Full Text (PDF)
• Cognitive impairments in multiple system atrophyMSA-C vs MSA-P

  Y. Kawai, M. Suenaga, A. Takeda, M. Ito, H. Watanabe, F. Tanaka, K. Kato, H. Fukatsu, S. Naganawa, T. Kato, K. Ito, G. Sobue

  • Abstract
  • Full Text
  • Full Text (PDF)
• FMR1 CGG repeat length predicts motor dysfunction in premutation carriers

  M. A. Leehey, E. Berry-Kravis, C. G. Goetz, L. Zhang, D. A. Hall, L. Li, C. D. Rice, R. Lara, J. Cogswell, A. Reynolds, L. Gane, S. Jacquemont, F. Tassone, J. Grigsby, R. J. Hagerman, P. J. Hagerman

  • Abstract
  • Full Text
  • Full Text (PDF)
• Globus pallidus dopamine and Parkinson motor subtypesClinical and brain biochemical correlation

  A. H. Rajput, H. H. Sitte, A. Rajput, M. E. Fenton, C. Pifl, O. Hornykiewicz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Midbrain iron content in early Parkinson diseaseA potential biomarker of disease status

  W. R. Wayne Martin, Marguerite Wieler, Myrlene Gee

  • Abstract
  • Full Text
  • Full Text (PDF)
• Statin use and the risk of Parkinson disease

  Angelika D. Wahner, Jeff M. Bronstein, Yvette M. Bordelon, Beate Ritz

  • Abstract
  • Full Text
  • Full Text (PDF)
• Parkinson disease and risk of mortalityA prospective comorbidity-matched cohort study

  J. A. Driver, T. Kurth, J. E. Buring, J. M. Gaziano, G. Logroscino

  • Abstract
  • Full Text
  • Full Text (PDF)
• Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease

  M. U. Ferraye, B. Debû, V. Fraix, J. Xie-Brustolin, S. Chabardès, P. Krack, A-L Benabid, P. Pollak

  • Abstract
  • Full Text
  • Full Text (PDF)
• Use of antihypertensives and the risk of Parkinson disease

  Claudia Becker, Susan S. Jick, Christoph R. Meier

  • Abstract
  • Full Text
  • Full Text (PDF)
• Subthalamic nucleus stimulation modulates audiospinal reactions in Parkinson disease

  M. Pötter, J. Herzog, H. R. Siebner, F. Kopper, F. Steigerwald, G. Deuschl, J. Volkmann

  • Abstract
  • Full Text
  • Full Text (PDF)
• Pathologic findings in prospectively ascertained essential tremor subjects

  H. A. Shill, C. H. Adler, M. N. Sabbagh, D. J. Connor, J. N. Caviness, J. G. Hentz, T. G. Beach

  • Abstract
  • Full Text
  • Full Text (PDF)
• Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease

  K. Haugarvoll, R. Rademakers, J. M. Kachergus, K. Nuytemans, O. A. Ross, J. M. Gibson, E-K Tan, C. Gaig, E. Tolosa, S. Goldwurm, M. Guidi, G. Riboldazzi, L. Brown, U. Walter, R. Benecke, D. Berg, T. Gasser, J. Theuns, P. Pals, P. Cras, P. Paul De Deyn, S. Engelborghs, B. Pickut, R. J. Uitti, T. Foroud, W. C. Nichols, J. Hagenah, C. Klein, A. Samii, C. P. Zabetian, V. Bonifati, C. Van Broeckhoven, M. J. Farrer, Z. K. Wszolek

  • Abstract
  • Full Text
  • Full Text (PDF)
• α-Synuclein, pesticides, and Parkinson diseaseA case–control study

  L. Brighina, R. Frigerio, N. K. Schneider, T. G. Lesnick, M. de Andrade, J. M. Cunningham, M. J. Farrer, S. J. Lincoln, H. Checkoway, W. A. Rocca, D. M. Maraganore

  • Abstract
  • Full Text
  • Full Text (PDF)
• Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

  C. Huang, P. Mattis, K. Perrine, N. Brown, V. Dhawan, D. Eidelberg

  • Abstract
  • Full Text
  • Full Text (PDF)